Colin P. Rae
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas.
Journal: Journal of hepatology
Published: October 11, 2024
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Journal: Gut
Published: July 26, 2023
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 05, 2022
Metabolic reprogramming in cholangiocarcinoma.
Journal: Journal of hepatology
Published: February 28, 2022
Receptor tyrosine kinase co-amplification and benefit from HER2 inhibitors in biliary tract cancers.
Receptor tyrosine kinase co-amplification and benefit from HER2 inhibitors in biliary tract cancers.
Journal: Journal of hepatology
Published: December 22, 2021
Patient-Derived Organoids as a Model for Cancer Drug Discovery.
Journal: International journal of molecular sciences
Published: February 27, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
Journal: Nature communications
Published: October 06, 2020
Cytotoxicity and Radiosensitizing Activity of the Fatty Acid Synthase Inhibitor C75 Is Enhanced by Blocking Fatty Acid Uptake in Prostate Cancer Cells.
Journal: Advances in radiation oncology
Published: February 29, 2020
Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids.
Journal: Cells
Published: February 24, 2020
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy.
Journal: Oncotarget
Published: November 22, 2018
Last Updated: 09/26/2026